Opioids for back and neck pain: the OPAL trial - Authors' reply

Affiliations

¹ Sydney Musculoskeletal Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia; The Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia.
² Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney and St Vincent's Clinical Campus, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
³ Department of General Practice, Erasmus MC, Rotterdam, Netherlands; Center for Muscle and Joint Health, University of Southern Denmark, Odense, Denmark.
⁴ Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.
⁵ The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
⁶ Sydney Musculoskeletal Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia; The Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia. Electronic address: christine.lin@sydney.edu.au.

Comment

Caitlin M P Jones et al. Lancet. 2024.

. 2024 Jun 1;403(10442):2379-2380.

doi: 10.1016/S0140-6736(24)00487-2.

¹ Sydney Musculoskeletal Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia; The Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia.
² Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney and St Vincent's Clinical Campus, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
³ Department of General Practice, Erasmus MC, Rotterdam, Netherlands; Center for Muscle and Joint Health, University of Southern Denmark, Odense, Denmark.
⁴ Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.
⁵ The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
⁶ Sydney Musculoskeletal Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia; The Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia. Electronic address: christine.lin@sydney.edu.au.

No abstract available

Comment on

Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial.
Jones CMP, Day RO, Koes BW, Latimer J, Maher CG, McLachlan AJ, Billot L, Shan S, Lin CC; OPAL Investigators Coordinators. Jones CMP, et al. Lancet. 2023 Jul 22;402(10398):304-312. doi: 10.1016/S0140-6736(23)00404-X. Epub 2023 Jun 28. Lancet. 2023. PMID: 37392748 Clinical Trial.